Windgap Medical, Inc. products

Current long-acting injectables require complicated preparation steps, often with dosing and degradation issues. Our in-device mixing mechanisms automate and control this process to protect the medication, the patient, and the outcome.

Lyophilized drugs can require multiple complicated steps—and take over two minutes—to administer a life-saving dose of rescue glucagon. Our self-administered ANDI® platform does it in two steps—and in seconds.

Liquid medications typically have a poor stability profile. Our wet-dry autoinjectors contain drugs in their most stable state, offering unprecedented temperature resilience, shelf life, and patient compliance.

This device is supported by an ongoing NIH grant and potential for follow-on funding.

The ANDIPEN is a wet/dry dual-chamber autoinjector built to drastically improve temperature resilience and shelf lives of medications traditionally offered and stored in liquid form. The ANDI® Platform is the basis for our epinephrine product, currently in pre-production in partnership with ALK-Abelló.